Trevi Therapeutics, Inc. (TRVI)
16.64
-0.18
(-1.10%)
USD |
NASDAQ |
Sep 09, 16:00
16.64
0.00 (0.00%)
After-Hours: 17:10
Trevi Therapeutics Shareholders Equity (Quarterly) : 321.51M for June 30, 2026
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 321.51M |
| March 31, 2026 | 172.13M |
| December 31, 2025 | 183.24M |
| September 30, 2025 | 189.79M |
| June 30, 2025 | 198.49M |
| March 31, 2025 | 99.46M |
| December 31, 2024 | 99.64M |
| September 30, 2024 | 58.97M |
| June 30, 2024 | 66.17M |
| March 31, 2024 | 72.33M |
| December 31, 2023 | 82.55M |
| September 30, 2023 | 89.61M |
| June 30, 2023 | 95.07M |
| March 31, 2023 | 101.73M |
| December 31, 2022 | 107.46M |
| September 30, 2022 | 109.90M |
| June 30, 2022 | 60.52M |
| March 31, 2022 | 10.46M |
| Date | Value |
|---|---|
| December 31, 2021 | 17.08M |
| September 30, 2021 | 11.38M |
| June 30, 2021 | 17.74M |
| March 31, 2021 | 23.68M |
| December 31, 2020 | 27.28M |
| September 30, 2020 | 35.62M |
| June 30, 2020 | 40.04M |
| March 31, 2020 | 46.80M |
| December 31, 2019 | 54.54M |
| September 30, 2019 | 60.71M |
| June 30, 2019 | 67.70M |
| March 31, 2019 | 12.68M |
| December 31, 2018 | 6.248M |
| September 30, 2018 | 12.04M |
| June 30, 2018 | |
| March 31, 2018 | |
| December 31, 2017 | 14.78M |
Shareholders' Equity Definition
Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| ANI Pharmaceuticals, Inc. | 597.21M |
| Corcept Therapeutics, Inc. | 705.78M |
| Veru, Inc. | 28.38M |
| Johnson & Johnson | 84.97B |
| Eli Lilly & Co. | 33.88B |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 330.52M |
| Total Liabilities (Quarterly) | 9.012M |
| Debt to Equity Ratio | 0.0019 |
| Current Ratio | 37.28 |
| Net Debt Paydown Yield | 0.00% |